Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Serial Profiling of SARS-CoV-2 Antigens and Antibodies in COVID-19 Patient Plasma

Alana F. Ogata, Adam M. Maley, Connie Wu, Tal Gilboa, Maia Norman, Roey Lazarovits, Chih-Ping Mao, Gail Newton, Matthew Chang, Katrina Nguyen, Maliwan Kamkaew, Quan Zhu, Travis E. Gibson, Edward T. Ryan, Richelle C. Charles, Wayne A. Marasco, David R. Walt
doi: https://doi.org/10.1101/2020.07.20.20156372
Alana F. Ogata
1Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA
2Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA
3Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam M. Maley
1Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA
2Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA
3Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Connie Wu
1Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA
2Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA
3Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tal Gilboa
1Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA
2Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA
3Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maia Norman
1Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA
2Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA
4Tufts University School of Medicine, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roey Lazarovits
1Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA
2Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chih-Ping Mao
1Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gail Newton
1Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Chang
5Department of Cancer Immunology and Virology Dana-Farber Cancer Institute, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katrina Nguyen
5Department of Cancer Immunology and Virology Dana-Farber Cancer Institute, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maliwan Kamkaew
5Department of Cancer Immunology and Virology Dana-Farber Cancer Institute, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Quan Zhu
5Department of Cancer Immunology and Virology Dana-Farber Cancer Institute, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Travis E. Gibson
1Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA
3Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward T. Ryan
6Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA
7Department of Medicine, Harvard Medical School, Boston, MA, USA
8Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richelle C. Charles
6Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA
7Department of Medicine, Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wayne A. Marasco
5Department of Cancer Immunology and Virology Dana-Farber Cancer Institute, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David R. Walt
1Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA
2Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA
3Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dwalt@bwh.harvard.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions of people worldwide. PCR tests are currently the gold standard for diagnosis of the current coronavirus disease (COVID-19) and serology tests are used to detect seroconversion in infected patients. However, there is a lack of quantitative and ultra-sensitive viral antigen tests for COVID-19. Here we show that Single Molecule Array (Simoa) assays can quantitatively detect SARS-CoV-2 spike, S1 subunit, and nucleocapsid antigens in the plasma of COVID-19 patients. Combined with Simoa anti-SARS-CoV-2 serological assays, we show correlation between production of antibodies and clearance of viral antigens from serial plasma samples from COVID-19 patients. Furthermore, we demonstrate the presence of viral antigens in blood correlates with disease severity in hospitalized COVID-19 patients. These data suggest that SARS-CoV-2 viral antigens in the blood could be a marker for severe COVID-19 cases.

One Sentence Summary SARS-CoV-2 antigens S1, spike, and nucleocapsid and anti-SARS-Cov-2 antibodies were measured in longitudinal plasma samples from COVID-19 patients using Single Molecule Array (Simoa) assays.

Competing Interest Statement

David Walt has a financial interest in Quanterix Corporation. He is an inventor the Simoa technology. He is a founder of the company and also serves on its Board of Directors. David Walt's interests were reviewed and are managed by BWH and Partners HealthCare in accordance with their COI policies. The serological Simoa assays in this publication have been licensed by BWH to Quanterix Corporation.

Funding Statement

Funding for this work came from a generous donation from Barbara and Amos Hostetter and the Chleck Foundation. This work was also funded through grants from the Massachusetts Consortium on Pathogen Readiness and the Centers for Disease Control and Prevention (U01CK000490).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Research described in this manuscript was approved by Mass General Brigham IRB.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All Data is available within the manuscript and Supporting Information.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted July 26, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Serial Profiling of SARS-CoV-2 Antigens and Antibodies in COVID-19 Patient Plasma
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Serial Profiling of SARS-CoV-2 Antigens and Antibodies in COVID-19 Patient Plasma
Alana F. Ogata, Adam M. Maley, Connie Wu, Tal Gilboa, Maia Norman, Roey Lazarovits, Chih-Ping Mao, Gail Newton, Matthew Chang, Katrina Nguyen, Maliwan Kamkaew, Quan Zhu, Travis E. Gibson, Edward T. Ryan, Richelle C. Charles, Wayne A. Marasco, David R. Walt
medRxiv 2020.07.20.20156372; doi: https://doi.org/10.1101/2020.07.20.20156372
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Serial Profiling of SARS-CoV-2 Antigens and Antibodies in COVID-19 Patient Plasma
Alana F. Ogata, Adam M. Maley, Connie Wu, Tal Gilboa, Maia Norman, Roey Lazarovits, Chih-Ping Mao, Gail Newton, Matthew Chang, Katrina Nguyen, Maliwan Kamkaew, Quan Zhu, Travis E. Gibson, Edward T. Ryan, Richelle C. Charles, Wayne A. Marasco, David R. Walt
medRxiv 2020.07.20.20156372; doi: https://doi.org/10.1101/2020.07.20.20156372

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (215)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1093)
  • Dentistry and Oral Medicine (195)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (499)
  • Epidemiology (9758)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2304)
  • Geriatric Medicine (222)
  • Health Economics (462)
  • Health Informatics (1554)
  • Health Policy (732)
  • Health Systems and Quality Improvement (602)
  • Hematology (236)
  • HIV/AIDS (501)
  • Infectious Diseases (except HIV/AIDS) (11634)
  • Intensive Care and Critical Care Medicine (616)
  • Medical Education (236)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2140)
  • Nursing (134)
  • Nutrition (335)
  • Obstetrics and Gynecology (426)
  • Occupational and Environmental Health (517)
  • Oncology (1172)
  • Ophthalmology (363)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (145)
  • Palliative Medicine (50)
  • Pathology (309)
  • Pediatrics (694)
  • Pharmacology and Therapeutics (298)
  • Primary Care Research (265)
  • Psychiatry and Clinical Psychology (2173)
  • Public and Global Health (4648)
  • Radiology and Imaging (775)
  • Rehabilitation Medicine and Physical Therapy (455)
  • Respiratory Medicine (623)
  • Rheumatology (274)
  • Sexual and Reproductive Health (225)
  • Sports Medicine (210)
  • Surgery (250)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)